{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:43Z","timestamp":1786985203821,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bioorg.2018.09.022","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T01:47:55Z","timestamp":1536803275000},"page":"587-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives"],"prefix":"10.1016","volume":"81","author":[{"given":"Mahasen M.","family":"Fouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman R.","family":"El-Bendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"suddek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan A.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"El-Kerdawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.09.022_b0005","unstructured":"WHO, Cancer <http:\/\/www.who.int\/cancer\/en\/>, 2018."},{"key":"10.1016\/j.bioorg.2018.09.022_b0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bioorg.2018.09.022_b0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejmech.2013.12.010","article-title":"Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo [2, 1-b] thiazole derivatives bearing pyrazole moieties","volume":"75","author":"Ali","year":"2014","journal-title":"Euro. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bioorg.2017.07.008","article-title":"Synthesis and anticancer activity of new thiazolo [3, 2-a] pyrimidines: DNA binding and molecular modeling study","volume":"74","author":"Hassan","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2017.08.066","article-title":"Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of cyclopenta (hepta)[b] thiophene and fused cyclohepta [b] thiophene analogs","volume":"140","author":"Abdel-Rahman","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0030","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/j.ejmech.2011.07.035","article-title":"Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agents","volume":"46","author":"Aly","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0035","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/ijms13033661","article-title":"Synthesis and antimicrobial studies of some novel bis-[1, 3, 4] thiadiazole and bis-thiazole pendant to thieno [2, 3-b] thiophene moiety","volume":"13","author":"Kheder","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2018.09.022_b0040","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0968-0896(02)00018-4","article-title":"Synthesis and in vitro antitumor activity of thiophene analogues of 5-chloro-5, 8-dideazafolic acid and 2-methyl-2-desamino-5-chloro-5, 8-dideazafolic acid","volume":"10","author":"Forsch","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0045","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.3390\/molecules16064937","article-title":"Microwave assisted synthesis of some new fused 1, 2, 4-triazines bearing thiophene moieties with expected pharmacological activity","volume":"16","author":"Saad","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.09.022_b0050","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.bmc.2013.03.061","article-title":"Design, synthesis and biological evaluation of novel 3, 4, 5-trisubstituted aminothiophenes as inhibitors of p53\u2013MDM2 interaction. Part 1","volume":"21","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0055","first-page":"159","article-title":"Syntheses, characterization and in-vitro anti-Inflammatory activity of some novel thiophenes","volume":"5","author":"Deka","year":"2012","journal-title":"Macedonian J. Med. Sci."},{"key":"10.1016\/j.bioorg.2018.09.022_b0060","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1016\/j.ejmech.2010.08.044","article-title":"Synthesis and screening of some novel fused thiophene and thienopyrimidine derivatives for anti-avian influenza virus (H5N1) activity","volume":"45","author":"Rashad","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmc.2011.11.023","article-title":"Novel inhibitors of epidermal growth factor receptor:(4-(Arylamino)-7H-pyrrolo [2, 3-d] pyrimidin-6-yl)(1H-indol-2-yl) methanones and (1H-indol-2-yl)(4-(phenylamino) thieno [2, 3-d] pyrimidin-6-yl) methanones","volume":"20","author":"Beckers","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cclet.2015.03.026","article-title":"Synthesis and antitumor activity of \u03b1-aminophosphonate derivatives containing thieno [2, 3-d] pyrimidines","volume":"26","author":"Guo","year":"2015","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.09.022_b0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejmech.2013.02.011","article-title":"Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno [2, 3-d] pyrimidine derivatives","volume":"63","author":"Kassab","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40242-013-3281-6","article-title":"Synthesis and antitumor activities of novel 4-morpholinothieno [3, 2-d] pyrimidine derivatives","volume":"30","author":"Song","year":"2014","journal-title":"Chem. Res. Chin. Univ."},{"key":"10.1016\/j.bioorg.2018.09.022_b0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/jhet.5570410613","article-title":"Synthesis of classical and nonclassical 2-amino-4-oxo-6-benzylthieno-[2, 3-d] pyrimidines as potential thymidylate synthase inhibitors","volume":"41","author":"Gangjee","year":"2004","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2014.01.042","article-title":"Structure\u2013activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor","volume":"75","author":"Bugge","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.fjps.2015.09.001","article-title":"Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents","volume":"1","author":"Elrazaz","year":"2015","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2018.09.022_b0100","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1016\/j.bmcl.2009.10.001","article-title":"Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo","volume":"19","author":"Luke","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.09.022_b0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bmcl.2008.12.011","article-title":"Thienopyrimidine-based dual EGFR\/ErbB-2 inhibitors","volume":"19","author":"Rheault","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.09.022_b0110","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1021\/jm100607r","article-title":"Design and synthesis of tetrahydropyridothieno [2, 3-d] pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and Michael acceptor group for maximal potency","volume":"53","author":"Wu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2018.09.022_b0115","first-page":"281","volume":"7","author":"Al-Ghorbani","year":"2015","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.bioorg.2018.09.022_b0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2478\/v10007-010-0027-6","article-title":"Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxidant and antitumor agents","volume":"60","author":"Abu-Hashem","year":"2010","journal-title":"Acta Pharm."},{"key":"10.1016\/j.bioorg.2018.09.022_b0125","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.ejmech.2010.01.013","article-title":"Synthesis and pharmacological evaluation of novel fused thiophene derivatives as 5-HT2A receptor antagonists: molecular modeling study","volume":"45","author":"El-Kerdawy","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jhet.5570370516","article-title":"Facile syntheses of homothia-and homoazacalixarenes","volume":"37","author":"Ito","year":"2000","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0135","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0223-5234(00)01187-9","article-title":"Design, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands","volume":"35","author":"Modica","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0140","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1021\/jm00117a019","article-title":"Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents","volume":"31","author":"Russell","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0145","first-page":"815","article-title":"Chemistry of 2-aminothiophene-3-carboxamide and related compounds","volume":"35","author":"Gouda","year":"2011","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0150","first-page":"152","volume":"vol","author":"Gronowitz","year":"2009","journal-title":"Thiophene and its derivatives"},{"key":"10.1016\/j.bioorg.2018.09.022_b0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1039\/a605368h","article-title":"1-Substituted 3-dimethylaminoprop-2-en-1-ones as building blocks in heterocyclic synthesis: routes to 6-aryl-and 6-heteroaryl-2H-pyran-2-ones and 6-and 4-arylpyridin-2 (1H)-ones","author":"Al-Omran","year":"1997","journal-title":"J. Chem. Res. Synop."},{"key":"10.1016\/j.bioorg.2018.09.022_b0160","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2478\/acph-2014-0035","article-title":"Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents","volume":"64","author":"Ghorab","year":"2014","journal-title":"Acta Pharm."},{"key":"10.1016\/j.bioorg.2018.09.022_b0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/80300333","article-title":"New Routes to Pyridino [2, 3-d] pyrimidin-4-one and Pyridino-[2, 3-d] triazolino [4, 5-a] pyrimidin-5-one Derivatives","volume":"8","author":"Hassneen","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.09.022_b0170","doi-asserted-by":"crossref","first-page":"o762","DOI":"10.1107\/S2056989015016217","article-title":"Crystal structure of ethyl 5-acetyl-2-{[(dimethylamino) methylidene] amino}-4-methylthiophene-3-carboxylate","volume":"71","author":"Prasad","year":"2015","journal-title":"Acta Crystallograp. Section E: Crystallograp. Commun."},{"key":"10.1016\/j.bioorg.2018.09.022_b0175","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1071\/CH9811729","article-title":"Methylation of heterocyclic compounds containing NH, SH and\/or OH groups by means of N, N-dimethylformamide dimethyl acetal","volume":"34","author":"Stanovnik","year":"1981","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0180","doi-asserted-by":"crossref","unstructured":"H. Wang, Comprehensive Organic Name Reactions, 2010.","DOI":"10.1002\/9780470638859"},{"key":"10.1016\/j.bioorg.2018.09.022_b0185","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1021\/ja1059922","article-title":"Development of a general palladium-catalyzed carbonylative Heck reaction of aryl halides","volume":"132","author":"Wu","year":"2010","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.bioorg.2018.09.022_b0190","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1002\/hlca.200490276","article-title":"Efficient coupling reactions of arylalkynes and aldehydes leading to the synthesis of enones","volume":"87","author":"Xu","year":"2004","journal-title":"Helvetica Chimica Acta"},{"key":"10.1016\/j.bioorg.2018.09.022_b0195","series-title":"Experimental organic chemistry: a miniscale & microscale approach","author":"Gilbert","year":"2015"},{"key":"10.1016\/j.bioorg.2018.09.022_b0200","first-page":"gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2018.09.022_b0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2018.09.022_b0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2011.12.013","article-title":"Synthesis and antitumor evaluation of some new 1, 3, 4-oxadiazole-based heterocycles","volume":"48","author":"Bondock","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.09.022_b0215","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/np50089a004","article-title":"A colorimetric microassay for the detection of agents that interact with DNA","volume":"55","author":"Burres","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2018.09.022_b0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00280-003-0625-9","article-title":"Thymidylate synthase inhibitors as anticancer agents: from bench to bedside","volume":"52","author":"Chu","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2018.09.022_b0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12885-015-1339-1","article-title":"DNA Polymerases as targets for gene therapy of hepatocellular carcinoma","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2018.09.022_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccr.2009.12.046","article-title":"DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1","volume":"17","author":"Martin","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2018.09.022_b0235","doi-asserted-by":"crossref","first-page":"15752","DOI":"10.18632\/oncotarget.4199","article-title":"Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells","volume":"6","author":"Poh","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2018.09.022_b0240","first-page":"36","article-title":"Tyrosine kinase receptor inhibitors: a new target for anticancer drug development","volume":"1","author":"Sb","year":"2012","journal-title":"J. PharmaSciTech"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818307338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818307338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:43:15Z","timestamp":1571877795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818307338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":48,"alternative-id":["S0045206818307338"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.09.022","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}